Citation Impact
Citing Papers
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
2011 StandoutScience
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
2009 StandoutScience
Organization and dynamics of human mitochondrial DNA
2004
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
Demethylation of 3-Methylthymine in DNA by Bacterial and Human DNA Dioxygenases
2004 StandoutNobel
Nuclear Control of Respiratory Chain Expression in Mammalian Cells
1997
Circulating mitochondrial DAMPs cause inflammatory responses to injury
2010 StandoutNature
Mitochondrial myopathy simulating spinal muscular atrophy
1996
Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
1993
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Decrease of 3243 A→G mtDNA Mutation from Blood in MELAS Syndrome: A Longitudinal Study
2001
Premature ageing in mice expressing defective mitochondrial DNA polymerase
2004 StandoutNature
Assessing the physiological concentration and targets of nitric oxide in brain tissue
2008
Glycopeptide-preferring Polypeptide GalNAc Transferase 10 (ppGalNAc T10), Involved in Mucin-type O-Glycosylation, Has a Unique GalNAc-O-Ser/Thr-binding Site in Its Catalytic Domain Not Found in ppGalNAc T1 or T2
2009 StandoutNobel
Nonalcoholic Fatty Liver Disease
2002 Standout
Mitochondrial diabetes mellitus: a review
1995
Emerging roles of tRNA in adaptive translation, signalling dynamics and disease
2014
What is the real physiological NO concentration in vivo?
2009
Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1
2006
Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1
1999 Standout
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
1998 StandoutNobel
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
2007
The Pathophysiology and Treatment of Hereditary Tyrosinemia Type 1
2001
Analysis of mtDNA Copy Number and Composition of Single Mitochondrial Particles Using Flow Cytometry and PCR
2000
A non-heme iron protein with heme tendencies: An investigation of the substrate specificity of thymine hydroxylase
1993
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Mitochondria: In Sickness and in Health
2012 Standout
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage
2002 StandoutNatureNobel
Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
2011 StandoutNobel
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
2004
Glial and neuronal control of brain blood flow
2010 StandoutNature
Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation
2011 StandoutNobel
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
2006
Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway
2000
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Capillary pericytes regulate cerebral blood flow in health and disease
2014 StandoutNature
Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA
1996
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
Genetic Analysis of the Role of the Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-inducible Factor (HIF) in Regulating HIF Transcriptional Target Genes
2004 StandoutNobel
Characterization and Novel Purification of Recombinant Human Protein C from Three Mammalian Cell Lines
1990
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression
1999
Atherosclerosis — An Inflammatory Disease
1999 Standout
Crystal Structure of the Non-heme Iron Dioxygenase PtlH in Pentalenolactone Biosynthesis
2007 StandoutNobel
The mitochondrial genome: structure, transcription, translation and replication
1999
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
2002 StandoutNature
Searching for genes affecting the structural integrity of the mitochondrial genome
1995
The Pathophysiology and Treatment of Sepsis
2003 Standout
Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor
2010 StandoutNobel
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study
2001
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
2015
The Hallmarks of Aging
2013 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Fe(II)/α-Ketoglutarate-Dependent Hydroxylases and Related Enzymes
2004
Amyotrophic Lateral Sclerosis
2001 Standout
Organic Solutes Rescue the Functional Defect in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator
2003
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
JBP1 and JBP2 are two distinct thymidine hydroxylases involved in J biosynthesis in genomic DNA of African trypanosomes
2009
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803
2002
Pacing-Induced Heart Failure in Dogs Enhances the Expression of p53 and p53-Dependent Genes in Ventricular Myocytes
1998
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
1H NMR, 13C NMR, and Computational DFT Studies of the Structure of 2-Acylcyclohexane-1,3-diones and Their Alkali Metal Salts in Solution
2006
Liposomal NAD+prevents diminished O2consumption by immunostimulated Caco-2 cells
2002
Composition and Dynamics of Human Mitochondrial Nucleoids
2003
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Reprogramming homing endonuclease specificity through computational design and directed evolution
2013 StandoutNobel
Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds
1972
Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle
2001
Renal function in tyrosinaemia type I after liver transplantation: A long‐term follow‐up
2005
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
Superresolution Fluorescence Imaging of Mitochondrial Nucleoids Reveals Their Spatial Range, Limits, and Membrane Interaction
2011
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
1995
Genes of the thymidine salvage pathway: Thymine-7-hydroxylase from a Rhodotorula glutinis cDNA library and iso-orotate decarboxylase from Neurospora crassa
2005
Metabolic reprogramming and cancer progression
2020 StandoutScience
Recombinant human protein C, protein S and thrombomodulin as antithrombotics
1994
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury
2004 StandoutNobel
Reversal of DNA alkylation damage by two human dioxygenases
2002 StandoutNobel
Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth
2014 StandoutNobel
Arene Oxides: A New Aspect of Drug Metabolism
1974 StandoutScience
Mitochondrial DNA mutations in disease and aging
2011
Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.
1994
Fas Is Expressed in Human Atherosclerotic Intima and Promotes Apoptosis of Cytokine-Primed Human Vascular Smooth Muscle Cells
1997
Increased mitochondrial mass in mitochondrial myopathy mice
2002
Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β
1996
Late-Onset Corticohippocampal Neurodepletion Attributable to Catastrophic Failure of Oxidative Phosphorylation in MILON Mice
2001
Expression of Inducible Nitric Oxide Synthase Inhibits Platelet Adhesion and Restores Blood Flow in the Injured Artery
1996
Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.
1995
Dioxygen Activation by Enzymes with Mononuclear Non-Heme Iron Active Sites
1996
Works of E. Holme being referenced
Leigh Syndrome with Cytochrome-c Oxidase Deficiency and a Single T Insertion nt 5537 in the Mitochondrial tRNATrpGene
2003
Tyrosinemia type III: diagnosis and ten‐year follow‐up
1997
Low Levels of Mitochondrial Transcription Factor A in Mitochondrial DNA Depletion
1994
Neuropathology in Kearns-Sayre syndrome
1990
Tyrosinaemia type I and NTBC (2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione)
1998
Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I
2003
Hepatocellular carcinoma despite long‐term survival in chronic tyrosinaemia I
2000
Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase.
1989 Nobel
Treatment of two children with hereditary tyrosinaemia type I and long‐standing renal disease with a 4‐hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)
1996
Outcome of tyrosinaemia type III
2001
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells.
1992
Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency.
1989
Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.
1993
Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A-->G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome.
1993
Segregation and manifestations of the mtDNA tRNA(Lys) A-->G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome.
1992
7-Hydroxylation of thymine in a neurospora strain coupled to oxidative decarboxylation of 2-ketoglutarate
1970